Viewing Study NCT06632093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-05-16 @ 4:20 AM
Study NCT ID: NCT06632093
Status: RECRUITING
Last Update Posted: 2024-10-08
First Post: 2024-10-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC
Sponsor: First Hospital of China Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None BCLC Stage B Hepatocellular Carcinoma View
None BCLC Stage C Hepatocellular Carcinoma View
None Hepatic Arterial Infusion Chemotherapy View
None Lenvatinib View
None PD-1 View
None Systemic Therapy View
Keywords: